61 related articles for article (PubMed ID: 21512674)
21. Does 18F-FDG PET/CT play a role in the differential diagnosis of parotid masses.
Rubello D; Nanni C; Castellucci P; Rampin L; Farsad M; Franchi R; Mariani G; Menaldo G; Fanti S
Panminerva Med; 2005 Sep; 47(3):187-9. PubMed ID: 16462726
[TBL] [Abstract][Full Text] [Related]
22. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
23. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
[TBL] [Abstract][Full Text] [Related]
25. Whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography images before and after chemotherapy for Kaposi sarcoma and highly active antiretrovirus therapy.
Morooka M; Ito K; Kubota K; Minamimoto R; Shida Y; Hasuo K; Ito T; Tasato D; Honda H; Teruya K; Kikuchi Y; Ohtomo K
Jpn J Radiol; 2010 Dec; 28(10):759-62. PubMed ID: 21191742
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of F-18 FDG PET/CT in a case of Kaposi sarcoma with an unexpected bone lesion.
Morooka M; Ito K; Kubota K; Yanagisawa K; Teruya K; Hasuo K; Shida Y; Minamimoto R; Kikuchi Y; Oka S
Clin Nucl Med; 2011 Mar; 36(3):231-4. PubMed ID: 21285687
[TBL] [Abstract][Full Text] [Related]
27. The response of HIV-associated lymphadenopathic Kaposi sarcoma to highly active antiretroviral therapy evaluated by 18F-FDG PET/CT.
Mankia SK; Miller RF; Edwards SG; Ramsay A; Lee SM
Clin Nucl Med; 2012 Jul; 37(7):692-3. PubMed ID: 22691516
[TBL] [Abstract][Full Text] [Related]
28. Conjunctival Kaposi's sarcoma with orbital extension in an HIV-negative man.
Coblentz J; Park JY; Discepola G; Arthurs B; Burnier M
Can J Ophthalmol; 2018 Jun; 53(3):e111-e113. PubMed ID: 29784173
[No Abstract] [Full Text] [Related]
29. Sirolimus monotherapy for Kaposi's sarcoma in an HIV-negative patient.
Weenink JJ; Groeneveld JO; de Fijter CW
Lancet Oncol; 2006 Oct; 7(10):875-6. PubMed ID: 17012050
[No Abstract] [Full Text] [Related]
30. Elevated FDG uptake in Kaposi sarcoma mimicking Hodgkin's lymphoma relapse.
Bonardel G; Coindre JM; Gontier E; Schlaifer D; Mantzarides M; Soret M; Foehrenbach H
Clin Nucl Med; 2008 Sep; 33(9):624-6. PubMed ID: 18716513
[No Abstract] [Full Text] [Related]
31. A challenging case of rapid progressive Kaposi sarcoma after renal transplantation: diagnostics by FDG PET/CT.
Reuter S; Vrachimis A; Huss S; Wardelmann E; Weckesser M; Pavenstädt H
Medicine (Baltimore); 2014 Sep; 93(11):e67. PubMed ID: 25192485
[TBL] [Abstract][Full Text] [Related]
32. Imaging of HIV-associated Kaposi sarcoma; F-18-FDG-PET/CT and In-111-bevacizumabscintigraphy.
van de Luijtgaarden A; van der Ven A; Leenders W; Kaal S; Flucke U; Oyen W; van der Graaf W
J Acquir Immune Defic Syndr; 2010 Aug; 54(4):444-6. PubMed ID: 20611036
[No Abstract] [Full Text] [Related]
33. 18F-FDG PET/CT findings in an HIV-infected patient with systemic Kaposi sarcoma.
Yin L; Lin Z; Meng Z
Pol Arch Intern Med; 2021 Jan; 131(1):78-80. PubMed ID: 33306291
[No Abstract] [Full Text] [Related]
34. An HIV-negative penil Kaposi's sarcoma.
Demir A; Temiz Y; Bozkurt SU; Erbarut I; Ilker Y
Int Urol Nephrol; 2004; 36(4):559-61. PubMed ID: 15787336
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's sarcoma involving a transplanted kidney, ureter and urinary bladder: ultrasound and CT findings.
Rha SE; Byun JY; Kim HH; Baek JH; Hwang TK; Kang SJ
Br J Radiol; 2000 Nov; 73(875):1221-3. PubMed ID: 11144804
[TBL] [Abstract][Full Text] [Related]
36. Kaposi sarcoma after bilateral lung transplantation.
Martinez S; McAdams HP; Youens KE
J Thorac Imaging; 2008 Feb; 23(1):50-3. PubMed ID: 18347522
[TBL] [Abstract][Full Text] [Related]
37. Orificial tuberculosis and Kaposi's sarcoma in an HIV-negative individual.
Chen YJ; Shieh PP; Shen JL
Clin Exp Dermatol; 2000 Jul; 25(5):393-7. PubMed ID: 11012593
[TBL] [Abstract][Full Text] [Related]
38. PET/CT imaging of HIV-negative Kaposi's sarcoma.
Sager S; Engin B; Kutlubay Z; Asa S; Sager SG; Gucluer B; Kanmaz B
Ir J Med Sci; 2013 Dec; 182(4):745-6. PubMed ID: 23526254
[No Abstract] [Full Text] [Related]
39. [Osseous Kaposi sarcoma without contiguous cutaneous lesion: interest of positron emission tomography imaging with Fluorodeoxyglucose-(18F)].
Paycha F; Mortier E; Sassi R; Mahjoub WK; Huchet V; Talbot JN
Presse Med; 2009 Feb; 38(2):327-33. PubMed ID: 18977631
[No Abstract] [Full Text] [Related]
40. Asymmetric relapse of an HIV-associated Kaposi sarcoma.
Bleibtreu A; Mahida B; Bouscarat F; Rioux C
Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):555-556. PubMed ID: 27832310
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
